<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:53:51Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9786771" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9786771</identifier>
        <datestamp>2022-12-24</datestamp>
        <setSpec>viruses</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Viruses</journal-id>
              <journal-id journal-id-type="iso-abbrev">Viruses</journal-id>
              <journal-id journal-id-type="publisher-id">viruses</journal-id>
              <journal-title-group>
                <journal-title>Viruses</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1999-4915</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9786771</article-id>
              <article-id pub-id-type="pmcid">PMC9786771</article-id>
              <article-id pub-id-type="pmc-uid">9786771</article-id>
              <article-id pub-id-type="pmid">36560767</article-id>
              <article-id pub-id-type="pmid">36560767</article-id>
              <article-id pub-id-type="doi">10.3390/v14122763</article-id>
              <article-id pub-id-type="publisher-id">viruses-14-02763</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>T Cell Transcriptional Signatures of Influenza A/H3N2 Antibody Response to High Dose Influenza and Adjuvanted Influenza Vaccine in Older Adults</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Haralambieva</surname>
                    <given-names>Iana H.</given-names>
                  </name>
                  <xref rid="af1-viruses-14-02763" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Quach</surname>
                    <given-names>Huy Quang</given-names>
                  </name>
                  <xref rid="af1-viruses-14-02763" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ovsyannikova</surname>
                    <given-names>Inna G.</given-names>
                  </name>
                  <xref rid="af1-viruses-14-02763" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Goergen</surname>
                    <given-names>Krista M.</given-names>
                  </name>
                  <xref rid="af2-viruses-14-02763" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Grill</surname>
                    <given-names>Diane E.</given-names>
                  </name>
                  <xref rid="af2-viruses-14-02763" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Poland</surname>
                    <given-names>Gregory A.</given-names>
                  </name>
                  <xref rid="af1-viruses-14-02763" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6164-4967</contrib-id>
                  <name>
                    <surname>Kennedy</surname>
                    <given-names>Richard B.</given-names>
                  </name>
                  <xref rid="af1-viruses-14-02763" ref-type="aff">1</xref>
                  <xref rid="c1-viruses-14-02763" ref-type="corresp">*</xref>
                  <xref rid="fn1-viruses-14-02763" ref-type="author-notes">†</xref>
                </contrib>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Russell</surname>
                    <given-names>Charles J.</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Hurwitz</surname>
                    <given-names>Julia L.</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Mousa</surname>
                    <given-names>Jarrod J.</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <aff id="af1-viruses-14-02763"><label>1</label>Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN 55905, USA</aff>
              <aff id="af2-viruses-14-02763"><label>2</label>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA</aff>
              <author-notes>
                <corresp id="c1-viruses-14-02763"><label>*</label>Correspondence: <email>kennedy.rick@mayo.edu</email>; Tel.: +1-(507)-284-4968; Fax: +1-(507)-266-4716</corresp>
                <fn id="fn1-viruses-14-02763">
                  <label>†</label>
                  <p>Current address: Co-Director, Mayo Clinic Vaccine Research Group, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>11</day>
                <month>12</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>12</month>
                <year>2022</year>
              </pub-date>
              <volume>14</volume>
              <issue>12</issue>
              <elocation-id>2763</elocation-id>
              <history>
                <date date-type="received">
                  <day>21</day>
                  <month>10</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>07</day>
                  <month>12</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2022 by the authors.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Older adults experience declining influenza vaccine-induced immunity and are at higher risk of influenza and its complications. For this reason, high dose (e.g., Fluzone) and adjuvanted (e.g., Fluad) vaccines are preferentially recommended for people age 65 years and older. However, T cell transcriptional activity shaping the humoral immune responses to Fluzone and Fluad vaccines in older adults is still poorly understood. We designed a study of 234 older adults (≥65 years old) who were randomly allocated to receive Fluzone or Fluad vaccine and provided blood samples at baseline and at Day 28 after immunization. We measured the humoral immune responses (hemagglutination inhibition/HAI antibody titer) to influenza A/H3N2 and performed mRNA-Seq transcriptional profiling in purified CD4<sup>+</sup> T cells, in order to identify T cell signatures that might explain differences in humoral immune response by vaccine type. Given the large differences in formulation (higher antigen dose vs adjuvant), our hypothesis was that each vaccine elicited a distinct transcriptomic response after vaccination. Thus, the main focus of our study was to identify the differential gene expression influencing the antibody titer in the two vaccine groups. Our analyses identified three differentially expressed, functionally linked genes/proteins in CD4<sup>+</sup> T cells: the calcium/calmodulin dependent serine/threonine kinase IV (CaMKIV); its regulator the TMEM38B/transmembrane protein 38B, involved in maintenance of intracellular Ca2<sup>+</sup> release; and the transcriptional coactivator CBP/CREB binding protein, as regulators of transcriptional activity/function in CD4<sup>+</sup> T cells that impact differences in immune response by vaccine type. Significantly enriched T cell-specific pathways/biological processes were also identified that point to the importance of genes/proteins involved in Th1/Th2 cell differentiation, IL-17 signaling, calcium signaling, Notch signaling, MAPK signaling, and regulation of TRP cation Ca2<sup>+</sup> channels in humoral immunity after influenza vaccination. In summary, we identified the genes/proteins and pathways essential for cell activation and function in CD4<sup>+</sup> T cells that are associated with differences in influenza vaccine-induced humoral immunity by vaccine type. These findings provide an additional mechanistic perspective for achieving protective immunity in older adults.</p>
              </abstract>
              <kwd-group>
                <kwd>influenza</kwd>
                <kwd>influenza vaccine</kwd>
                <kwd>hemagglutination inhibition</kwd>
                <kwd>humoral</kwd>
                <kwd>immunity</kwd>
                <kwd>gene expression profiling</kwd>
                <kwd>transcriptome</kwd>
                <kwd>genetic markers</kwd>
                <kwd>T cells</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>National Institute of Allergy</funding-source>
                  <funding-source>Infectious Diseases of the National Institutes of Health</funding-source>
                  <award-id>R01AI132348</award-id>
                </award-group>
                <award-group>
                  <funding-source>Center for Influenza Vaccine Research for High Risk Populations (CIVR-HRP)</funding-source>
                  <award-id>75N93019C00052</award-id>
                </award-group>
                <funding-statement>This research was funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health with grant number R01AI132348, the Center for Influenza Vaccine Research for High Risk Populations (CIVR-HRP) with contract number 75N93019C00052 (CIVIC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.</funding-statement>
              </funding-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-viruses-14-02763">
              <title>1. Introduction</title>
              <p>Influenza causes considerable morbidity and mortality, with an annual illness burden of 9–41 million cases, leading to 140,000–710,000 hospitalizations and 12,000–52,000 deaths during the 2010–2020 time period in the United States [<xref rid="B1-viruses-14-02763" ref-type="bibr">1</xref>]. Although the influenza virus can infect people of any age group and disease severity varies, a significantly higher risk of serious influenza complications is evident in older adults. As a result, older adults constitute 50 to 70% of influenza-associated hospitalizations and 70–85% of influenza-linked deaths [<xref rid="B2-viruses-14-02763" ref-type="bibr">2</xref>,<xref rid="B3-viruses-14-02763" ref-type="bibr">3</xref>,<xref rid="B4-viruses-14-02763" ref-type="bibr">4</xref>,<xref rid="B5-viruses-14-02763" ref-type="bibr">5</xref>]. Seasonal influenza vaccination remains the best way to prevent influenza and its complications [<xref rid="B6-viruses-14-02763" ref-type="bibr">6</xref>]. However, older adults are often insufficiently protected by vaccination [<xref rid="B7-viruses-14-02763" ref-type="bibr">7</xref>], due to the gradual decline of immune system response mechanisms with aging, often referred to as immunosenescence [<xref rid="B8-viruses-14-02763" ref-type="bibr">8</xref>].</p>
              <p>In the United States, two influenza vaccines are recommended for adults ≥65 years old: high-dose inactivated influenza vaccine (Fluzone) and adjuvanted inactivated influenza vaccine (Fluad). During the period of our study, both vaccines contained the influenza A/Michigan/45/2015 (H1N1)pdm09-like virus hemagglutinin (HA), the A/Singapore/INFIMH-16-0019/2016 A(H3N2)-like virus HA, and the B/Colorado/06/2017-like (Victoria lineage) virus HA. Each dose of the Fluzone (high-dose) vaccine contains 60 µg of HA per strain (4-fold higher than the standard dose influenza vaccine), and Fluad (adjuvanted vaccine) contains 15 µg HA (equivalent to the standard dose vaccine), formulated with MF59 adjuvant. Both the Fluzone and Fluad vaccines elicit superior antibody responses, compared to standard dose influenza vaccines [<xref rid="B9-viruses-14-02763" ref-type="bibr">9</xref>,<xref rid="B10-viruses-14-02763" ref-type="bibr">10</xref>,<xref rid="B11-viruses-14-02763" ref-type="bibr">11</xref>]. The high-dose Fluzone vaccine induces higher HAI titers than the standard-dose vaccine and demonstrates better protection and a reduced risk of respiratory-related hospitalization in older adults of ≥65 years old [<xref rid="B9-viruses-14-02763" ref-type="bibr">9</xref>,<xref rid="B12-viruses-14-02763" ref-type="bibr">12</xref>]. Similarly, the Fluad adjuvanted vaccine was also found to be more effective in protecting older adults from pneumonia and influenza-related hospitalization, compared to the standard-dose, non-adjuvanted vaccine [<xref rid="B13-viruses-14-02763" ref-type="bibr">13</xref>,<xref rid="B14-viruses-14-02763" ref-type="bibr">14</xref>]. The relative effectiveness (in subjects ≥ 65 years old) of adjuvanted influenza vaccine was found to be greater, compared to the high-dose influenza vaccine, during the 2017–2018 and 2018–2019 influenza seasons [<xref rid="B15-viruses-14-02763" ref-type="bibr">15</xref>]. Hence, a better understanding of the immunologic mechanisms driving influenza vaccine immunogenicity and efficacy is critical not only to enhance vaccine effectiveness, but also to design better influenza vaccines for older individuals. Herein, we comprehensively investigate the transcriptional and immune responses to the Fluzone and Fluad vaccines in 234 adults ≥ 65 years old and identify differential transcriptional immune signatures in CD4<sup>+</sup> T cells, underlying the differences in antibody titers in vaccine recipients of the Fluzone and Fluad vaccines. This work sheds further light on mechanistic explanations, regarding the the observed differences in vaccine-induced humoral immunity (influenza A/H3N2 HAI antibody titer) by vaccine type.</p>
            </sec>
            <sec sec-type="methods" id="sec2-viruses-14-02763">
              <title>2. Methods</title>
              <p>The following methods are similar or identical to our previously published studies [<xref rid="B16-viruses-14-02763" ref-type="bibr">16</xref>,<xref rid="B17-viruses-14-02763" ref-type="bibr">17</xref>,<xref rid="B18-viruses-14-02763" ref-type="bibr">18</xref>,<xref rid="B19-viruses-14-02763" ref-type="bibr">19</xref>,<xref rid="B20-viruses-14-02763" ref-type="bibr">20</xref>].</p>
              <sec id="sec2dot1-viruses-14-02763">
                <title>2.1. Study Subjects</title>
                <p>This study was approved by The Mayo Clinic Institutional Review Board (IRB# 17-010601).</p>
                <p>During the period of August to December 2018, we enrolled 234 healthy subjects, aged ≥ 65 years, who were randomly allocated to receive either high-dose influenza vaccine (Fluzone) or MF59-adjuvanted influenza vaccine (Fluad). Both inactivated vaccines contained antigens of the: (i) H1N1 (A/Michigan/45/2015/pdm09-like strain), (ii) H3N2 (A/Singapore/INFIMH-16-0019/2016-like strain), and (iii) B lineage (Colorado/06/2017-like Victoria lineage strain) strains. Blood draws were obtained on all subjects at baseline (prior to vaccination) and 28 days following vaccination. Written informed consent was obtained from each subject at the time of enrollment. All subjects were asked to provide their vaccination histories and report their health status. During the study, study subjects were excluded if they exhibited symptoms related to influenza.</p>
              </sec>
              <sec id="sec2dot2-viruses-14-02763">
                <title>2.2. Processing Blood Samples</title>
                <p>Blood samples were collected and processed as previously published [<xref rid="B19-viruses-14-02763" ref-type="bibr">19</xref>]. Briefly, blood (100 mL) was collected from each subject at two different time points: day 0 (baseline before immunization) and day 28 after immunization (peak of humoral immune responses). Each blood sample included: (i) 90 mL of blood collected in 9 BD Vacutainer<sup>®</sup> tubes containing lithium heparin (anticoagulant) that was used for isolation of peripheral bone mononuclear cells (PBMCs), and (ii) 10 mL of blood collected in 2 BD Vacutainer<sup>®</sup> tubes (containing clot activator) that was used for the preparation of serum. PBMCs were isolated by gradient centrifugation using Ficoll Paque Plus tube (GE Healthcare Life Sciences, Uppsala, Sweden), following the manufacturer’s instructions. Isolated PBMCs were resuspended in freezing media (20% heat-inactivated FCS, 10% DMSO in RPMI) at 1 × 10<sup>7</sup> cells/mL and stored in liquid nitrogen for future use. For serum, blood tubes were centrifuged at 2000× <italic toggle="yes">g</italic> for 15 min at room temperature. Serum was collected from the supernatant after centrifugation and stored at −80 °C.</p>
              </sec>
              <sec id="sec2dot3-viruses-14-02763">
                <title>2.3. Influenza Hemagglutination Inhibition (HAI) Assay</title>
                <p>Hemagglutination inhibition (HAI) assays were performed using the influenza A/H3N2 virus (A/Singapore/INFIMH-16-0019/2016/H3N2 strain), in accordance with WHO guidelines [<xref rid="B20-viruses-14-02763" ref-type="bibr">20</xref>] and following an optimized protocol, as previously published [<xref rid="B17-viruses-14-02763" ref-type="bibr">17</xref>]. Briefly, sera were treated with receptor-destroying enzyme (RDE) from <italic toggle="yes">Vibrio cholerae</italic> filtrate (Sigma-Aldrich, St. Louis, MO, USA) to eliminate non-specific inhibitors of hemagglutination. Treated sera were two-fold serially diluted with PBS in a V-bottom 96-well plate. Diluted sera (25 µL) were mixed with 25 µL of standardized influenza A/H3N2 virus solution containing 4 hemagglutination units (HAU) and incubated for 30 min at room temperature. Then, 0.5% turkey red blood cell suspension (50 µL) was added to the mixture. The HAI titer were determined after 45 min incubation and defined as the reciprocal of the highest serum dilution that completely inhibited hemagglutination. All dilutions were tested in triplicate. A positive pooled control serum was run with each batch of samples. The coefficient of variation (CV) of the HAI assay in our laboratory was 2.9% [<xref rid="B21-viruses-14-02763" ref-type="bibr">21</xref>].</p>
              </sec>
              <sec id="sec2dot4-viruses-14-02763">
                <title>2.4. mRNA Sequencing</title>
                <p>mRNA next-generation sequencing was performed using similar protocols, as described in our previous publications [<xref rid="B16-viruses-14-02763" ref-type="bibr">16</xref>,<xref rid="B18-viruses-14-02763" ref-type="bibr">18</xref>,<xref rid="B22-viruses-14-02763" ref-type="bibr">22</xref>]. Briefly, untouched CD4<sup>+</sup> Tcells were first isolated from PBMCs via negative selection (depletion of non-target cells expressing CD8, CD14, CD15, CD16, CD19, CD34, CD36, CD56, CD123, and CD235a), using the Miltenyi Biotec’s Pan-T cell isolation kit, CD8 specific magnetic microbeads, LS columns, and a MidiMACS™ Separator. Total RNA was extracted from isolated cells using the RNeasy Plus Mini Kit and RNAprotect reagent (Qiagen, Valencia, CA, USA). RNA quantity and quality were assessed by Nanodrop (Thermo Fisher Scientific, Wilmington, DE, USA) and Agilent 2010 Bioanalyzer (Agilent, Palo Alto, CA, USA) assays. The TruSeq<sup>®</sup> Stranded mRNA Library Prep v2 (Illumina, San Diego, CA, USA) was used to create cDNA libraries, following the manufacturer’s protocol at Mayo Clinic’s Gene Sequencing Core Facility. Illumina’s NovaSeq 6000 S2 Reagent Kit (100 cycles) was used to perform paired-end read sequencing on the Illumina NovaSeq 6000 Instrument. The MAP-RSeq version 3.0 pipeline was used to align reads using STAR to the hg38 human reference genome, and gene expression counts were obtained using featureCounts, utilizing the gene definition files from Ensembl v78 [<xref rid="B23-viruses-14-02763" ref-type="bibr">23</xref>]. Conditional quantile regression was used for normalization [<xref rid="B24-viruses-14-02763" ref-type="bibr">24</xref>]. All gene expression values within each gene were scaled to have a mean of zero and a standard deviation of one prior to analyses.</p>
              </sec>
              <sec id="sec2dot5-viruses-14-02763">
                <title>2.5. Statistical Analysis</title>
                <p>Differences between vaccine types were tested with Wilcoxon rank sum test for continuous variables and Pearson’s chi-squared test for discrete variables. To assess the effect of both gene expression and vaccine type on the immune outcome, we fit linear regression models with each gene and immune response variable. The dependent variables in the models were scaled gene expression, vaccine type, and the interaction between vaccine type and gene expression (i.e., interaction model). An interaction model with a significant interaction term/finding indicates that the predicted immune response trajectory is different for each vaccine for the specified gene. Interaction plots are presented, showing the predicted immune response separately for each vaccine type across the scaled gene expression. In all our models, the immune outcome was defined as the log2 influenza A/H3N2 HAI titer (Day 28–Day 0). Due to the large number of tests, false discovery rate q-values (for the per gene comparison analyses) were calculated using Storey’s method [<xref rid="B25-viruses-14-02763" ref-type="bibr">25</xref>]. In the per-gene analyses, we set significance thresholds at <italic toggle="yes">p</italic> ≤ 0.005/q ≤ 0.2. Gene set enrichment analysis was conducted using the ClusterProfiler package in R, and the online KEGG module and pathway data sets [<xref rid="B26-viruses-14-02763" ref-type="bibr">26</xref>]. We restricted the geneset size to be between 3 and 800. FDR for the pathway analysis were calculated using Benjamini–Hochberg method [<xref rid="B27-viruses-14-02763" ref-type="bibr">27</xref>].</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3-viruses-14-02763">
              <title>3. Results</title>
              <sec id="sec3dot1-viruses-14-02763">
                <title>3.1. Demographic and Immune Response Characteristics for the Study Cohort</title>
                <p>Of 250 subjects initially enrolled for this study, 9 subjects were excluded due to the lack of vaccination history and 7 subjects withdrew during the study. Of the 234 subjects who completed all study visits for blood sampling, 146 (62.4%) were females and 88 (37.6%) were males (<xref rid="viruses-14-02763-f001" ref-type="fig">Figure 1</xref>, <xref rid="viruses-14-02763-t001" ref-type="table">Table 1</xref>). The racial/ethnicity characteristics of the study subjects reflected the Olmsted County population, with Hispanics and African Americans constituting only 1.7% and 0.4% of the study subjects, respectively (<xref rid="viruses-14-02763-t001" ref-type="table">Table 1</xref>). An equal number of subjects (n = 117) were randomly allocated to receive either high-dose Fluzone or MF59-adjuvated Fluad vaccine (<xref rid="viruses-14-02763-t001" ref-type="table">Table 1</xref>). Demographic variables were comparable between the two groups, including height, weight, and BMI measurements (<xref rid="viruses-14-02763-t001" ref-type="table">Table 1</xref>). In our previous studies, demographic variables have been found to significantly impact vaccine-induced immune responses [<xref rid="B8-viruses-14-02763" ref-type="bibr">8</xref>,<xref rid="B19-viruses-14-02763" ref-type="bibr">19</xref>,<xref rid="B28-viruses-14-02763" ref-type="bibr">28</xref>]. Since demographic/clinical variables in this study were not significantly different between our two vaccine groups, this allowed us to investigate the impact of the influenza vaccine type on immune responses, without these confounding differences between groups. Both vaccines were immunogenic and resulted in a rise in influenza A/H3N2 HAI antibody titer, relative to the baseline (<xref rid="app1-viruses-14-02763" ref-type="app">Supplementary Figure S1</xref>), with no statistically significant differences in antibody response between males and females (data not shown). The HAI Ab titer change against influenza A/H3N2 virus (log<sub>2</sub> change in HAI titer from Day 0 to Day 28, <xref rid="viruses-14-02763-t001" ref-type="table">Table 1</xref>, <xref rid="app1-viruses-14-02763" ref-type="app">Supplementary Figure S1</xref>) demonstrated a slightly higher response in the Fluzone vaccine recipients, although this difference did not reach statistical significance between the two cohorts (<italic toggle="yes">p</italic> = 0.06, <xref rid="viruses-14-02763-t001" ref-type="table">Table 1</xref>).</p>
              </sec>
              <sec id="sec3dot2-viruses-14-02763">
                <title>3.2. Humoral Immune Response to Fluad and Fluzone Vaccination Is Shaped by Differential CD4<sup>+</sup> T Cell Gene Expression</title>
                <p>We tested the hypothesis that vaccine-induced immunity/immunogenicity occurs through different activation of T cell help by vaccine type, and these differences are influenced by gene expression in the CD4<sup>+</sup> T cell population. To do this, we conducted three interaction modeling analyses, allowing for the effect of gene expression to vary by vaccine type, in order to assess the effect on immune outcome. These included: interaction model 1, where we assessed the effect of the Day 28/Day 0 gene expression change; interaction model 2, where we assessed the effect of the baseline/Day 0 gene expression; and interaction model 3, where we assessed the effect of Day 28 gene expression. The immune outcome in all analyses is defined as the log2 influenza A/H3N2 HAI titer (Day 28–Day 0). Significance thresholds at <italic toggle="yes">p</italic> ≤ 0.005/q ≤ 0.2 were used in these analyses.</p>
                <p>First, we explored the influence of CD4<sup>+</sup> T cell transcriptomic changes over time (Day 28/Day 0 gene expression changes—interaction model 1) on HAI antibody titer following vaccination. This model identified 128 genes that meet our significance criteria (<xref rid="viruses-14-02763-t002" ref-type="table">Table 2</xref>, <xref rid="app1-viruses-14-02763" ref-type="app">Supplementary Figure S2, Supplementary Table S1</xref>). The majority of these genes/factors have no known direct immune function, but are involved in cellular processes in T cells, such as cell signaling, metabolism, transcription, and membrane trafficking, with a plausible or established link to immune processes (<xref rid="viruses-14-02763-t002" ref-type="table">Table 2</xref>, <xref rid="app1-viruses-14-02763" ref-type="app">Supplementary Table S1</xref>). Among our major significant findings, we identified <italic toggle="yes">CAMK4</italic>, which encodes the calcium-/calmodulin-dependent serine/threonine kinase IV (CaMKIV), (<italic toggle="yes">p</italic> = 0.0008, q = 0.1575, <xref rid="viruses-14-02763-t002" ref-type="table">Table 2</xref>). Another significant gene of interest (<italic toggle="yes">TMEM38B</italic>) is linked to CAMKIV function and encodes a cation channel protein involved in the regulation of intracellular calcium [<xref rid="B29-viruses-14-02763" ref-type="bibr">29</xref>]. These observations are consistent with the reported role of CAMKIV in the development of humoral immunity after influenza vaccination in previous system vaccinology studies [<xref rid="B30-viruses-14-02763" ref-type="bibr">30</xref>,<xref rid="B31-viruses-14-02763" ref-type="bibr">31</xref>,<xref rid="B32-viruses-14-02763" ref-type="bibr">32</xref>]. Similar to these previous reports, we found that <italic toggle="yes">CAMK4</italic> gene expression was negatively associated with antibody titer in our overall study cohort (gene estimate −0.4262, <italic toggle="yes">p</italic> = 0.0006, data not shown), but also demonstrated that this gene/factor is likely involved in the differential activation of T cell help by vaccine type (<xref rid="viruses-14-02763-f002" ref-type="fig">Figure 2</xref>). <xref rid="viruses-14-02763-f002" ref-type="fig">Figure 2</xref> visualizes the differential effect of <italic toggle="yes">CAMK4</italic> and several functionally-related genes on the immune outcome in the two vaccine groups. These significant genes were selected for display from interaction model 1, because they were functionally linked and previously reported (for <italic toggle="yes">CAMK4</italic>) to influence immune responses following influenza vaccination [<xref rid="B30-viruses-14-02763" ref-type="bibr">30</xref>,<xref rid="B31-viruses-14-02763" ref-type="bibr">31</xref>,<xref rid="B32-viruses-14-02763" ref-type="bibr">32</xref>]. The negative association of the <italic toggle="yes">CAMK4</italic> gene expression change with the immune outcome was quite pronounced for the Fluad vaccine. Conversely, there was a very slight positive association for the Fluzone vaccine (<xref rid="viruses-14-02763-f002" ref-type="fig">Figure 2</xref>). Of note, similar differential patterns were observed for other important genes, as well (<xref rid="viruses-14-02763-f002" ref-type="fig">Figure 2</xref>). Slightly below our significance/false discovery rate thresholds (with <italic toggle="yes">p</italic> = 0.0086, q = 0.2562, <xref rid="viruses-14-02763-t002" ref-type="table">Table 2</xref>), we also identified a third CAMKIV-linked gene/factor, the <italic toggle="yes">CREBBP</italic>/CREB binding protein (CBP), which is a transcriptional coactivator of CREB (a master regulator of transcription in T cells) regulated by nuclear Ca<sup>2+</sup> and CaMKIV [<xref rid="B33-viruses-14-02763" ref-type="bibr">33</xref>].</p>
                <p>Among the top 20 genes (<xref rid="viruses-14-02763-t002" ref-type="table">Table 2</xref>), we also identified four members of the solute carrier family proteins (<italic toggle="yes">SLC2A11</italic>, <italic toggle="yes">SLC38A5</italic>, <italic toggle="yes">SLC25A53</italic>, <italic toggle="yes">SLC23A3</italic>) that are metabolic regulators of T cell differentiation and function [<xref rid="B29-viruses-14-02763" ref-type="bibr">29</xref>] and have a role in innate and inflammatory responses in macrophages [<xref rid="B34-viruses-14-02763" ref-type="bibr">34</xref>,<xref rid="B35-viruses-14-02763" ref-type="bibr">35</xref>]. Other interesting genes with a role in T cell differentiation/activation/function from interaction model 1 include: <italic toggle="yes">PLEKHG5</italic>/pleckstrin homology and RhoGEF domain containing G5 (a protein that activates the NF-kappa-B signaling pathway); <italic toggle="yes">PIAS3</italic>/protein inhibitor of activated STAT 3; <italic toggle="yes">TRAF7</italic>/TNF receptor associated factor 7; <italic toggle="yes">GATA3</italic>/GATA binding protein 3 (transcriptional regulator of Th2 differentiation/function); and IL36A/interleukin 36 alpha (a protein that can activate NF-kappa-B and MAPK signaling pathways, involved in inflammation (<xref rid="viruses-14-02763-t002" ref-type="table">Table 2</xref>). All significant genes from interaction model 1 are listed in <xref rid="app1-viruses-14-02763" ref-type="app">Supplementary Table S1</xref>.</p>
                <p>Second, we explored the interaction of the genes by vaccine type, for Day 0 (baseline) gene expression (interaction model 2) or Day 28 gene expression (interaction model 3) on the antibody response/HAI titer (Day 28–Day 0) (<xref rid="viruses-14-02763-t003" ref-type="table">Table 3</xref>). Although we observed a few interesting immune signaling and regulatory factors among our top findings from these models (i.e., <italic toggle="yes">PIAS3</italic>/protein inhibitor of activated STAT 3 (also identified in interaction model 1, described above); <italic toggle="yes">NLRX1</italic>/NLR family member X1, a versatile immune regulatory protein [<xref rid="B36-viruses-14-02763" ref-type="bibr">36</xref>]; and <italic toggle="yes">POGLUT1</italic>/ protein O-glucosyltransferase 1, an important regulator of Notch signaling, see <xref rid="viruses-14-02763-t003" ref-type="table">Table 3</xref>), the resultant findings did not meet our statistical threshold and must be interpreted with caution.</p>
              </sec>
              <sec id="sec3dot3-viruses-14-02763">
                <title>3.3. Biological Pathways and Immune Functions in T Cells Associated with the Immune Response by Vaccine Type</title>
                <p>To better understand the biological processes and pathways controlled by the differentially expressed genes in CD4<sup>+</sup> T cells between the Fluad and Fluzone vaccine recipients, we performed pathway enrichment analysis on all the genes from interaction model 1. This analysis identified pathways/biological functions that are significantly represented in our results, capturing the effects of genes/factors below the significance threshold. We used pathway definitions from MSigDB’s index of KEGG canonical pathways (see Statistical Methods) [<xref rid="B37-viruses-14-02763" ref-type="bibr">37</xref>]. In the enrichment analysis, we used a significance/false discovery rate threshold of q ≤ 0.05 (<xref rid="viruses-14-02763-t004" ref-type="table">Table 4</xref>) for pathway identification. We found 42 significantly enriched pathways, of which 7 have been associated with non-influenza viral infections and mostly included overlapping inflammatory and innate genes (<xref rid="viruses-14-02763-t004" ref-type="table">Table 4</xref>). A total of 11 of the 42 significantly enriched pathways were directly related to T cell differentiation, activation, and/or function, with a variety of signal transduction, transcription-related, effector, and other genes involved in Th1/Th2 cell differentiation, TNF signaling pathway, Notch signaling pathway, MAPK signaling pathway, IL-17 signaling pathway, calcium signaling pathway, regulation of transient receptor potential (TRP) cation channels (stress-sensitive Ca<sup>2+</sup>-permeable ion channels), rap1/GTPase signaling pathway (important for the interaction between T cells and APCs, finetuning TCR signaling, and T cell responses) [<xref rid="B38-viruses-14-02763" ref-type="bibr">38</xref>], and tight junction and apoptosis (<xref rid="viruses-14-02763-t004" ref-type="table">Table 4</xref>, T cell-related pathways highlighted in bold). Significantly enriched pathways based on genes from interaction models 2 and 3 are presented in <xref rid="app1-viruses-14-02763" ref-type="app">Supplementary Table S2</xref>. Pathways linked to T cell activity, such as Th1/Th2 cell differentiation, Th17 cell differentiation, and multiple signaling pathways, were also found to be enriched (<xref rid="app1-viruses-14-02763" ref-type="app">Supplementary Table S2</xref>).</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec4-viruses-14-02763">
              <title>4. Discussion</title>
              <p>High-dose Fluzone and adjuvanted Fluad vaccines are known to induce a more robust humoral immune response in older adults than conventional influenza vaccines, with a consequent increase in protection against influenza. However, little is known about T cell transcriptional signatures shaping the humoral response to these vaccines in older adults, who are at risk of immunosenescence-related decrease in immune function (i.e., have suboptimal vaccine-induced immunity) and at higher risk of influenza and influenza-linked complications. The major focus of our study was to identify transcriptional immune signatures in the T helper cell compartment and the possible mechanisms underlying differences in vaccine-induced humoral immunity between the Fluzone and Fluad vaccines in older adults (≥65 years old). We hypothesized that T cell signaling and function play an essential role in those differences and employed an immune response modeling approach using the interaction of CD4<sup>+</sup> T cell gene expression by vaccine type.</p>
              <p>The goal of our research efforts was to find T cell genes differentially influencing the immune response/antibody titer in the two vaccine groups. Our per-gene modeling efforts identified at least three functionally-linked proteins, i.e., the multifunctional CaMKIV kinase, one of its regulators/activators (transmembrane protein 38B, involved in maintenance of intracellular Ca2<sup>+</sup> release), and its immediate interacting partner (the CREB binding protein/CBP), as pivotal players in the T-cell signaling events and transcriptional regulation in CD4<sup>+</sup> T cells, thus resulting in antigen-specific activation of T cells and differential functional activity impacting humoral immunity. Importantly, we did observe a differential effect of other identified genes in each vaccine group, which significantly influenced the HAI antibody titer (<xref rid="viruses-14-02763-f002" ref-type="fig">Figure 2</xref>), as expected from our appied modeling strategies.</p>
              <p>A different approach (microarray-based gene expression on RNA extracted from PBMCs) has been previously used to compare the immune responses in subjects immunized with either trivalent inactivated influenza vaccine or live attenuated influenza vaccine and led to the discovery of the role of CaMKIV kinase (gene expression at day 3) in the negative regulation of influenza vaccine humoral immunity [<xref rid="B30-viruses-14-02763" ref-type="bibr">30</xref>,<xref rid="B31-viruses-14-02763" ref-type="bibr">31</xref>,<xref rid="B32-viruses-14-02763" ref-type="bibr">32</xref>]. The role of CaMKIV in influenza vaccine immunity was validated in vivo, in a CaMKIV-deficient mouse model, in which influenza vaccination led to higher antibody titers [<xref rid="B30-viruses-14-02763" ref-type="bibr">30</xref>]. Furthermore, <italic toggle="yes">CAMK4</italic> was identified as one of the top genes of a geneset/cluster (linked to T cell activation) that was associated with reduced cellular immune responses (IFN-γ, IL-2 cytokine secretion) after influenza vaccination in 138 healthy older adults [<xref rid="B39-viruses-14-02763" ref-type="bibr">39</xref>]. Gene signatures (derived from gene expression in PBMCs) linked to innate immune function (such as the Toll-like receptor-linked immune signature, inflammatory monocyte-linked signature, antiviral interferon signature, and dendritic cell function-linked signature) were found to be correlated with HAI antibody titer at day 28, when comparing trivalent inactivated influenza vaccine with MF59-adjuvanted trivalent inactivated vaccine in 14- to 24-months old children [<xref rid="B40-viruses-14-02763" ref-type="bibr">40</xref>]. Importantly, the MF59-adjuvanted vaccine was demonstrated to induce a higher frequency of antigen-specific polyfunctional CD4<sup>+</sup> T cells in the latter study [<xref rid="B40-viruses-14-02763" ref-type="bibr">40</xref>], although the underlying mechanism and/or link to humoral immunity remains unknown. Our study identified pathways and functions linked to adaptive immunity/T cell immune fuinction, rather than innate immunity, (e.g., T cell differentiation, T cell activation, and T cell-linked signaling) to influnece the antibody response induced by MF59-adjuvanted vs. high-dose influenza vaccine in older adults. This suggests that differences of induced immune responses to these vaccines may vary by age, most likely due to differences in immune system components/function and immune memory in different age groups (older adults vs. very young children). Furthermore, non-specific vaccine components, such as adjuvants, may have differential effect on immune function dependent on age.</p>
              <p>Our findings (CAMKIV, TMEM38B, CBP) are functionally linked to the downstream regulation/activation of the <italic toggle="yes">CREB</italic> gene, which encodes for the cAMP-responsive element binding protein (CREB), a transcription factor involved in different cellular responses, such as cell proliferation, cell survival, cell differentiation, and effector functions [<xref rid="B41-viruses-14-02763" ref-type="bibr">41</xref>]. It is often triggered by extracellular stimuli (e.g., glutamate, growth, and inflammatory stimuli), activated by phosphorylation to initiate, carry forward, and facilitate transcriptional programmes of immune genes (among other genes) containing cAMP-responsive elements. Many T cell function-specific genes also contain cAMP-responsive elements (e.g., <italic toggle="yes">IL2</italic>, <italic toggle="yes">IL10</italic>, <italic toggle="yes">TNF</italic>, <italic toggle="yes">TCRA/TCRα</italic>, <italic toggle="yes">TCRB/TCR Vβ</italic>, <italic toggle="yes">CD3D/CD3δ</italic>, <italic toggle="yes">CD8A/CD8α</italic>, <italic toggle="yes">CD25/IL2RA</italic>, <italic toggle="yes">IL2RG</italic>), suggesting that CREB is a master regulator of transcriptional activity in T cells, with a major role in Th1, Th2, and Th17 differentiation, the generation/maintenance of Tregs, and T cell effector function [<xref rid="B41-viruses-14-02763" ref-type="bibr">41</xref>]. Its role in T cells is illuminated in transgenic CREB mutant mice with dominant negative/transcriptionally inactive CREB, where defects in T cell proliferation, T cell function (IL-2 production), and apoptosis were demonstrated [<xref rid="B42-viruses-14-02763" ref-type="bibr">42</xref>]. Similar models demonstrate defects in T helper effector function (IL-4 and IFN-γ production), with failure to mount an antigen-specific antibody response [<xref rid="B43-viruses-14-02763" ref-type="bibr">43</xref>]. Recent findings in murine models also point to the instrumental role of CAMKIV for the expansion of Tfh lymphocytes and for the regulation of humoral immune responses through control over the <italic toggle="yes">BCL6</italic> gene expression [<xref rid="B44-viruses-14-02763" ref-type="bibr">44</xref>].</p>
              <p>The optimal activation/phosphorylation and transcription factor binding of CREB during T cell activation requires (in addition to the activation of the kinase cascade PKA, PKC, MAPK ERK1/2, p38, and MSK1/2 [<xref rid="B41-viruses-14-02763" ref-type="bibr">41</xref>,<xref rid="B45-viruses-14-02763" ref-type="bibr">45</xref>,<xref rid="B46-viruses-14-02763" ref-type="bibr">46</xref>]) the engagement of both CD3 and CD28, as well as the recruitment/binding of the CREB-binding protein/CBP to CREB, which, in turn, is thoroughly dependent on p38 MAPK and CaMKIV activation [<xref rid="B46-viruses-14-02763" ref-type="bibr">46</xref>]. In addition, both kinases are engaged in CREB phosphorylation, and CaMKIV alone is able to activate/phosphorylate CBP (controlled in addition by nuclear Ca2<sup>+</sup>) at Ser301 [<xref rid="B33-viruses-14-02763" ref-type="bibr">33</xref>,<xref rid="B46-viruses-14-02763" ref-type="bibr">46</xref>,<xref rid="B47-viruses-14-02763" ref-type="bibr">47</xref>]. Thus, CAMKIV and its functionally linked partners (CBP and transmembrane protein 38B) are instrumental for the CREB-based transcriptional activity in T cells.</p>
              <p>CaMKIV kinase signals via the calcium-dependent CaMKK-CaMK4 cascade and is activated upon increase of the intracellular Ca<sup>2+</sup> concentration (controlled by proteins such as the transmembrane protein 38B/TMEM38B) and calmodulin. As described above, its function/expression is indispensable for the optimal stimulation of CREB/CBP-activated transcriptional programs in T cells, and in particular, CD4<sup>+</sup> T cells with a memory phenotype [<xref rid="B48-viruses-14-02763" ref-type="bibr">48</xref>]. In addition to the above-mentioned downstream effects, transcription factor CREB is essential for innate immune function through the inhibition of NF-kB activation in monocytes/macrophages to limit inflammation and promote survival, as well as for survival of dendritic cells upon TLR stimulation [<xref rid="B41-viruses-14-02763" ref-type="bibr">41</xref>,<xref rid="B49-viruses-14-02763" ref-type="bibr">49</xref>].</p>
              <p>Our results also emphasize the significance of other T cell-specific transcription factors from our per-gene interaction model 1, such as the GATA binding protein 3, a major regulator of Th2 T cell differentiation, which regulates the expression of Th2 cytokines [<xref rid="B50-viruses-14-02763" ref-type="bibr">50</xref>], and/or other regulatory factors and signal transducers involved in MAPK and NF-kB signaling, Notch signaling, Jak-STAT signaling, and TNF signaling. Consistent with this, our pathway enrichment analysis points to most of these pathways and biological processes and, in particular, to pathway/biological functions linked to the CaMKIV-CBP-CREB activation and downstream effects in T cells (calcium signaling pathway, regulation of TRP Ca2<sup>+</sup>-permeable cation channels, IL-17 signaling pathway, and Th1/Th2 differentiation, among others).</p>
              <p>The strengths of our study include the randomized study design, as well as the use of a high-dimensional dataset linked to a specific cell type—purified CD4<sup>+</sup> T cells. Of the three models we used in our analysis approach, the most significant and biologically relevant findings come from interaction model 1, where we assessed the effect of transcriptomic changes over time (rather than baseline/Day 0 and Day 28 gene expression).</p>
              <p>The major limitation is the possibility of false positive findings, which is addressed by using <italic toggle="yes">p</italic>-value/q-value thresholds. The potential for type II error also exists, given the relatively limited numbers of individuals studied, and our results may or may not be generalizable to other races and/or ethnicities, other than the population we studied. Regardless, our analytical approach allowed us to identify transcriptomic signatures that modify vaccine-induced immunity of the two influenza vaccines we studied, leading to a better biologic understanding. The differential effect of some of the identified genes (<xref rid="viruses-14-02763-f002" ref-type="fig">Figure 2</xref>) on immune function/outcome in the two vaccine groups is unclear mechanistically, but could be linked to the differential trigerring (vs. no influence for example) of specific immune pathways (e.g., calcium signaling and Ca<sup>2+</sup> signaling-linked T cell activation) by an adjuvant or higher antigen dose. For example, it is demonstrated that MF59 induces the release of extracellular ATP, which, in turn, can influence the transport of Ca<sup>2+</sup> against elecrochemical gradient (which is ATP-dependent) and, thus, have an impact on calcium signaling and T cell activation [<xref rid="B51-viruses-14-02763" ref-type="bibr">51</xref>,<xref rid="B52-viruses-14-02763" ref-type="bibr">52</xref>]. An important limitation in our study is the lack of functional validation of our major targets and pathways, which is planned for future studies.</p>
              <p>Collectively, our study identified important T cell factors and functions regulating influenza vaccine humoral immunity by vaccine type and highlinging possible differences in their mechanism of action. Further validation and new analyses regarding these unique data are in progress, including the modeling of cellular immune response outcomes following vaccination.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>We would like to thank all of the participants in this study. We are grateful to financial support from NIAID and CIVR-HRP.</p>
            </ack>
            <fn-group>
              <fn>
                <p><bold>Publisher’s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <app-group>
              <app id="app1-viruses-14-02763">
                <title>Supplementary Materials</title>
                <p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/v14122763/s1">https://www.mdpi.com/article/10.3390/v14122763/s1</uri>, Figure S1: Antibody response by vaccine type; Figure S2: Significant findings from interaction model 1; Table S1: Influence of vaccine type and CD4+ T cell gene expression change on Ab response to influenza vaccination - full list of significant genes from interaction model 1; Table S2: Enriched biological pathways/processes involved in the immune outcome by vaccine type (from interaction model 2 [Day 0 gene expression effect] and from interaction model 3 [Day 28 gene expression effect])</p>
                <supplementary-material id="viruses-14-02763-s001" position="float" content-type="local-data">
                  <media xlink:href="viruses-14-02763-s001.zip">
                    <caption>
                      <p>Click here for additional data file.</p>
                    </caption>
                  </media>
                </supplementary-material>
              </app>
            </app-group>
            <notes>
              <title>Author Contributions</title>
              <p>I.H.H., I.G.O., G.A.P., and R.B.K. were involved in the conceptualization of the study. I.H.H., H.Q.Q., I.G.O., R.B.K., and D.E.G. were involved in the data acquisition, methodology of the study and in the visualization of the study results. K.M.G. and D.E.G. performed statistical analyses. R.B.K. and G.A.P. were involved in the funding acquisition and project administration. All authors were involved in the writing, editing, and revising of the manuscript. All authors have read and agreed to the published version of the manuscript. </p>
            </notes>
            <notes>
              <title>Institutional Review Board Statement</title>
              <p>The study was conducted in accordance with the Declaration of Helsinki, and approved by the Mayo Clinic Institutional Review Board (IRB# 17-010601).</p>
            </notes>
            <notes>
              <title>Informed Consent Statement</title>
              <p>Written, informed consent was obtained from each subject at the time of enrollment for this study.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability Statement</title>
              <p>All data included in the current study are available from the corresponding author upon reasonable request.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Poland provides consultative advice to: AiZtech; AstraZeneca UK Limited; Eli Lilly and Company; Emergent Biosolutions; Exelixis, Inc.; Genevant Sciences, Inc.; GlaxoSmithKline; Janssen Global Services, LLC; Krog &amp; Partners, Inc.; Medicago USA; Merck &amp; Co., Inc.; Moderna; Novavax; Pfizer-BNT; Regeneron Pharmaceuticals, Inc.; Sanofi; Syneos Health; Valneva and Vyriad. Poland is an adviser to the White House and World Health Organization on Covid-19 vaccines and monkeypox. Drs. Poland and Ovsyannikova hold patents related to vaccinia and measles peptide vaccines. Drs. Kennedy, Poland, and Ovsyannikova hold a patent related to vaccinia peptide vaccines. Drs. Poland, Kennedy, Ovsyannikova, and Haralambieva hold a patent related to the impact of single nucleotide polymorphisms on measles vaccine immunity. Drs. Poland, Kennedy, and Ovsyannikova have received grant funding from ICW Ventures for preclinical studies on a peptide-based COVID-19 vaccine. Kennedy has received funding from Merck Research Laboratories to study waning immunity to mumps vaccine. Kennedy also offers consultative advice on vaccine development to Merck &amp; Co. and Sanofi Pasteur. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies.</p>
            </notes>
            <ref-list>
              <title>References</title>
              <ref id="B1-viruses-14-02763">
                <label>1.</label>
                <element-citation publication-type="gov">
                  <comment>Available online: <ext-link xlink:href="https://www.cdc.gov/flu/about/burden/index.html" ext-link-type="uri">https://www.cdc.gov/flu/about/burden/index.html</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2022-12-05">(accessed on 5 December 2022)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B2-viruses-14-02763">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <article-title>Estimates of deaths associated with seasonal influenza—United States, 1976–2007</article-title>
                  <source>MMWR Morb. Mortal. Wkly. Rep.</source>
                  <year>2010</year>
                  <volume>59</volume>
                  <fpage>1057</fpage>
                  <lpage>1062</lpage>
                  <pub-id pub-id-type="pmid">20798667</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-viruses-14-02763">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reed</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Chaves</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Daily Kirley</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Emerson</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Aragon</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Hancock</surname>
                      <given-names>E.B.</given-names>
                    </name>
                    <name>
                      <surname>Butler</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Baumbach</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hollick</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Bennett</surname>
                      <given-names>N.M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Estimating influenza disease burden from population-based surveillance data in the United States</article-title>
                  <source>PLoS ONE</source>
                  <year>2015</year>
                  <volume>10</volume>
                  <elocation-id>e0118369</elocation-id>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0118369</pub-id>
                  <?supplied-pmid 25738736?>
                  <pub-id pub-id-type="pmid">25738736</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-viruses-14-02763">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhou</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>W.W.</given-names>
                    </name>
                    <name>
                      <surname>Viboud</surname>
                      <given-names>C.G.</given-names>
                    </name>
                    <name>
                      <surname>Ringholz</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>P.Y.</given-names>
                    </name>
                    <name>
                      <surname>Steiner</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Abedi</surname>
                      <given-names>G.R.</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>L.J.</given-names>
                    </name>
                    <name>
                      <surname>Brammer</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Shay</surname>
                      <given-names>D.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008</article-title>
                  <source>Clin. Infect. Dis.</source>
                  <year>2012</year>
                  <volume>54</volume>
                  <fpage>1427</fpage>
                  <lpage>1436</lpage>
                  <pub-id pub-id-type="doi">10.1093/cid/cis211</pub-id>
                  <?supplied-pmid 22495079?>
                  <pub-id pub-id-type="pmid">22495079</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-viruses-14-02763">
                <label>5.</label>
                <element-citation publication-type="gov">
                  <comment>Available online: <ext-link xlink:href="https://www.cdc.gov/flu/highrisk/65over.htm" ext-link-type="uri">https://www.cdc.gov/flu/highrisk/65over.htm</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2022-12-05">(accessed on 5 December 2022)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B6-viruses-14-02763">
                <label>6.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>World Health Organization</collab>
                  </person-group>
                  <source>Global Influenza Strategy 2019–2030</source>
                  <publisher-name>World Health Organization</publisher-name>
                  <publisher-loc>Geneva, Switzerland</publisher-loc>
                  <year>2019</year>
                </element-citation>
              </ref>
              <ref id="B7-viruses-14-02763">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goodwin</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Viboud</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Simonsen</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Antibody response to influenza vaccination in the elderly: A quantitative review</article-title>
                  <source>Vaccine</source>
                  <year>2006</year>
                  <volume>24</volume>
                  <fpage>1159</fpage>
                  <lpage>1169</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2005.08.105</pub-id>
                  <?supplied-pmid 16213065?>
                  <pub-id pub-id-type="pmid">16213065</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-viruses-14-02763">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Haralambieva</surname>
                      <given-names>I.H.</given-names>
                    </name>
                    <name>
                      <surname>Painter</surname>
                      <given-names>S.D.</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Ovsyannikova</surname>
                      <given-names>I.G.</given-names>
                    </name>
                    <name>
                      <surname>Lambert</surname>
                      <given-names>N.D.</given-names>
                    </name>
                    <name>
                      <surname>Goergen</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Oberg</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Poland</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects</article-title>
                  <source>PLoS ONE</source>
                  <year>2015</year>
                  <volume>10</volume>
                  <elocation-id>e0122282</elocation-id>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0122282</pub-id>
                  <pub-id pub-id-type="pmid">25816015</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-viruses-14-02763">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>DiazGranados</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Dunning</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Kimmel</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kirby</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Treanor</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Collins</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Pollak</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Christoff</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Earl</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Landolfi</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy of high-dose versus standard-dose influenza vaccine in older adults</article-title>
                  <source>N. Engl. J. Med.</source>
                  <year>2014</year>
                  <volume>371</volume>
                  <fpage>635</fpage>
                  <lpage>645</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa1315727</pub-id>
                  <pub-id pub-id-type="pmid">25119609</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-viruses-14-02763">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Domnich</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Arata</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Amicizia</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Puig-Barberà</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Gasparini</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Panatto</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis</article-title>
                  <source>Vaccine</source>
                  <year>2017</year>
                  <volume>35</volume>
                  <fpage>513</fpage>
                  <lpage>520</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.12.011</pub-id>
                  <pub-id pub-id-type="pmid">28024956</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-viruses-14-02763">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Frey</surname>
                      <given-names>S.E.</given-names>
                    </name>
                    <name>
                      <surname>Reyes</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Reynales</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Bermal</surname>
                      <given-names>N.N.</given-names>
                    </name>
                    <name>
                      <surname>Nicolay</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Narasimhan</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Forleo-Neto</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Arora</surname>
                      <given-names>A.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of the safety and immunogenicity of an MF59<sup>®</sup>-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects</article-title>
                  <source>Vaccine</source>
                  <year>2014</year>
                  <volume>32</volume>
                  <fpage>5027</fpage>
                  <lpage>5034</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.07.013</pub-id>
                  <pub-id pub-id-type="pmid">25045825</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-viruses-14-02763">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gravenstein</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Davidson</surname>
                      <given-names>H.E.</given-names>
                    </name>
                    <name>
                      <surname>Taljaard</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ogarek</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Gozalo</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Mor</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: A cluster-randomised trial</article-title>
                  <source>Lancet Respir. Med.</source>
                  <year>2017</year>
                  <volume>5</volume>
                  <fpage>738</fpage>
                  <lpage>746</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2213-2600(17)30235-7</pub-id>
                  <pub-id pub-id-type="pmid">28736045</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-viruses-14-02763">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lapi</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Marconi</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Simonetti</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Baldo</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Rossi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Sessa</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Cricelli</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly</article-title>
                  <source>Expert Rev. Vaccines</source>
                  <year>2019</year>
                  <volume>18</volume>
                  <fpage>663</fpage>
                  <lpage>670</lpage>
                  <pub-id pub-id-type="doi">10.1080/14760584.2019.1622418</pub-id>
                  <pub-id pub-id-type="pmid">31155968</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-viruses-14-02763">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McConeghy</surname>
                      <given-names>K.W.</given-names>
                    </name>
                    <name>
                      <surname>Davidson</surname>
                      <given-names>H.E.</given-names>
                    </name>
                    <name>
                      <surname>Canaday</surname>
                      <given-names>D.H.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Saade</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Mor</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Gravenstein</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cluster-randomized Trial of Adjuvanted Versus Nonadjuvanted Trivalent Influenza Vaccine in 823 US Nursing Homes</article-title>
                  <source>Clin. Infect. Dis.</source>
                  <year>2021</year>
                  <volume>73</volume>
                  <fpage>e4237</fpage>
                  <lpage>e4243</lpage>
                  <pub-id pub-id-type="doi">10.1093/cid/ciaa1233</pub-id>
                  <?supplied-pmid 32882710?>
                  <pub-id pub-id-type="pmid">32882710</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-viruses-14-02763">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boikos</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Fischer</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>O’Brien</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Vasey</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sylvester</surname>
                      <given-names>G.C.</given-names>
                    </name>
                    <name>
                      <surname>Mansi</surname>
                      <given-names>J.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenza Seasons</article-title>
                  <source>Clin. Infect. Dis.</source>
                  <year>2021</year>
                  <volume>73</volume>
                  <fpage>816</fpage>
                  <lpage>823</lpage>
                  <pub-id pub-id-type="doi">10.1093/cid/ciab152</pub-id>
                  <?supplied-pmid 33605977?>
                  <pub-id pub-id-type="pmid">33605977</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-viruses-14-02763">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Haralambieva</surname>
                      <given-names>I.H.</given-names>
                    </name>
                    <name>
                      <surname>Eberhard</surname>
                      <given-names>K.G.</given-names>
                    </name>
                    <name>
                      <surname>Ovsyannikova</surname>
                      <given-names>I.G.</given-names>
                    </name>
                    <name>
                      <surname>Grill</surname>
                      <given-names>D.E.</given-names>
                    </name>
                    <name>
                      <surname>Schaid</surname>
                      <given-names>D.J.</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Poland</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Transcriptional signatures associated with rubella virus-specific humoral immunity after a third dose of MMR vaccine in women of childbearing age</article-title>
                  <source>Eur. J. Immunol.</source>
                  <year>2021</year>
                  <volume>51</volume>
                  <fpage>1824</fpage>
                  <lpage>1838</lpage>
                  <pub-id pub-id-type="doi">10.1002/eji.202049054</pub-id>
                  <?supplied-pmid 33818775?>
                  <pub-id pub-id-type="pmid">33818775</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-viruses-14-02763">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaufmann</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Syedbasha</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Vogt</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Hollenstein</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Hartmann</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Linnik</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Egli</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>An optimized hemagglutination inhibition (HI) assay to quantify influenza-specific antibody titers</article-title>
                  <source>J. Vis. Exp.</source>
                  <year>2017</year>
                  <fpage>55833</fpage>
                  <pub-id pub-id-type="doi">10.3791/55833</pub-id>
                  <pub-id pub-id-type="pmid">29286466</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-viruses-14-02763">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ovsyannikova</surname>
                      <given-names>I.G.</given-names>
                    </name>
                    <name>
                      <surname>Salk</surname>
                      <given-names>H.M.</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Haralambieva</surname>
                      <given-names>I.H.</given-names>
                    </name>
                    <name>
                      <surname>Zimmermann</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Grill</surname>
                      <given-names>D.E.</given-names>
                    </name>
                    <name>
                      <surname>Oberg</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Poland</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Gene signatures associated with adaptive humoral immunity following seasonal influenza A/H1N1 vaccination</article-title>
                  <source>Genes Immun.</source>
                  <year>2016</year>
                  <volume>17</volume>
                  <fpage>371</fpage>
                  <lpage>379</lpage>
                  <pub-id pub-id-type="doi">10.1038/gene.2016.34</pub-id>
                  <pub-id pub-id-type="pmid">27534615</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-viruses-14-02763">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Quach</surname>
                      <given-names>H.Q.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Monroe</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Ratishvili</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Warner</surname>
                      <given-names>N.D.</given-names>
                    </name>
                    <name>
                      <surname>Grill</surname>
                      <given-names>D.E.</given-names>
                    </name>
                    <name>
                      <surname>Haralambieva</surname>
                      <given-names>I.H.</given-names>
                    </name>
                    <name>
                      <surname>Ovsyannikova</surname>
                      <given-names>I.G.</given-names>
                    </name>
                    <name>
                      <surname>Poland</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>R.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>The influence of sex, BMI, and age on cellular and humoral immune responses against measles after a 3rd dose of MMR vaccine</article-title>
                  <source>J. Infect. Dis.</source>
                  <year>2022</year>
                  <fpage>jiac351</fpage>
                  <pub-id pub-id-type="doi">10.1093/infdis/jiac351</pub-id>
                  <pub-id pub-id-type="pmid">35994504</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-viruses-14-02763">
                <label>20.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Webster</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Cox</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Stöhr</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <source>WHO Animal Influenza Manual</source>
                  <comment>WHO/CDS/CSR/NCS/2002.5</comment>
                  <publisher-name>World Health Organization</publisher-name>
                  <publisher-loc>Geneva, Switzerland</publisher-loc>
                  <year>2002</year>
                </element-citation>
              </ref>
              <ref id="B21-viruses-14-02763">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zimmermann</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Grill</surname>
                      <given-names>D.E.</given-names>
                    </name>
                    <name>
                      <surname>Oberg</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Goergen</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Ovsyannikova</surname>
                      <given-names>I.G.</given-names>
                    </name>
                    <name>
                      <surname>Haralambieva</surname>
                      <given-names>I.H.</given-names>
                    </name>
                    <name>
                      <surname>Poland</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Integration of Immune Cell Populations, mRNA-Seq, and CpG Methylation to Better Predict Humoral Immunity to Influenza Vaccination: Dependence of mRNA-Seq/CpG Methylation on Immune Cell Populations</article-title>
                  <source>Front. Immunol.</source>
                  <year>2017</year>
                  <volume>8</volume>
                  <fpage>445</fpage>
                  <pub-id pub-id-type="doi">10.3389/fimmu.2017.00445</pub-id>
                  <pub-id pub-id-type="pmid">28484452</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-viruses-14-02763">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Haralambieva</surname>
                      <given-names>I.H.</given-names>
                    </name>
                    <name>
                      <surname>Ovsyannikova</surname>
                      <given-names>I.G.</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Zimmermann</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Grill</surname>
                      <given-names>D.E.</given-names>
                    </name>
                    <name>
                      <surname>Oberg</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Poland</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Transcriptional signatures of influenza A/H1N1-specific IgG memory-like B cell response in older individuals</article-title>
                  <source>Vaccine</source>
                  <year>2016</year>
                  <volume>34</volume>
                  <fpage>3993</fpage>
                  <lpage>4002</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.06.034</pub-id>
                  <pub-id pub-id-type="pmid">27317456</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-viruses-14-02763">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kalari</surname>
                      <given-names>K.R.</given-names>
                    </name>
                    <name>
                      <surname>Nair</surname>
                      <given-names>A.A.</given-names>
                    </name>
                    <name>
                      <surname>Bhavsar</surname>
                      <given-names>J.D.</given-names>
                    </name>
                    <name>
                      <surname>O’Brien</surname>
                      <given-names>D.R.</given-names>
                    </name>
                    <name>
                      <surname>Davila</surname>
                      <given-names>J.I.</given-names>
                    </name>
                    <name>
                      <surname>Bockol</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Nie</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Baheti</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Doughty</surname>
                      <given-names>J.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>MAP-RSeq: Mayo analysis pipeline for RNA sequencing</article-title>
                  <source>BMC Bioinform.</source>
                  <year>2014</year>
                  <volume>15</volume>
                  <elocation-id>224</elocation-id>
                  <pub-id pub-id-type="doi">10.1186/1471-2105-15-224</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-viruses-14-02763">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hansen</surname>
                      <given-names>K.D.</given-names>
                    </name>
                    <name>
                      <surname>Irizarry</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Removing technical variability in RNA-seq data using conditional quantile normalization</article-title>
                  <source>Biostatistics</source>
                  <year>2012</year>
                  <volume>13</volume>
                  <fpage>204</fpage>
                  <lpage>216</lpage>
                  <pub-id pub-id-type="doi">10.1093/biostatistics/kxr054</pub-id>
                  <pub-id pub-id-type="pmid">22285995</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-viruses-14-02763">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Storey</surname>
                      <given-names>J.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>False Discovery Rate</article-title>
                  <source>Int. Encycl. Stat. Sci.</source>
                  <year>2011</year>
                  <volume>1</volume>
                  <fpage>504</fpage>
                  <lpage>508</lpage>
                </element-citation>
              </ref>
              <ref id="B26-viruses-14-02763">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yu</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L.-G.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>He</surname>
                      <given-names>Q.-Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>clusterProfiler: An R package for comparing biological themes among gene clusters</article-title>
                  <source>OMICS J. Integr. Biol.</source>
                  <year>2012</year>
                  <volume>16</volume>
                  <fpage>284</fpage>
                  <lpage>287</lpage>
                  <pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
                  <?supplied-pmid 22455463?>
                  <pub-id pub-id-type="pmid">22455463</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-viruses-14-02763">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Benjamini</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Hochberg</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Controlling the false discovery rate: A practical and powerful approach to multiple testing</article-title>
                  <source>J. R. Stat. Soc. Ser. B</source>
                  <year>1995</year>
                  <volume>57</volume>
                  <fpage>289</fpage>
                  <lpage>300</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-viruses-14-02763">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Voigt</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Ovsyannikova</surname>
                      <given-names>I.G.</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Grill</surname>
                      <given-names>D.E.</given-names>
                    </name>
                    <name>
                      <surname>Goergen</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Schaid</surname>
                      <given-names>D.J.</given-names>
                    </name>
                    <name>
                      <surname>Poland</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Sex differences in older adults’ immune responses to seasonal influenza vaccination</article-title>
                  <source>Front. Immunol.</source>
                  <year>2019</year>
                  <volume>10</volume>
                  <fpage>180</fpage>
                  <pub-id pub-id-type="doi">10.3389/fimmu.2019.00180</pub-id>
                  <pub-id pub-id-type="pmid">30873150</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-viruses-14-02763">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Song</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Tao</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Solute carrier transporters: The metabolic gatekeepers of immune cells</article-title>
                  <source>Acta Pharm. Sin. B</source>
                  <year>2020</year>
                  <volume>10</volume>
                  <fpage>61</fpage>
                  <lpage>78</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.apsb.2019.12.006</pub-id>
                  <pub-id pub-id-type="pmid">31993307</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-viruses-14-02763">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nakaya</surname>
                      <given-names>H.I.</given-names>
                    </name>
                    <name>
                      <surname>Wrammert</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>E.K.</given-names>
                    </name>
                    <name>
                      <surname>Racioppi</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Marie-Kunze</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Haining</surname>
                      <given-names>W.N.</given-names>
                    </name>
                    <name>
                      <surname>Means</surname>
                      <given-names>A.R.</given-names>
                    </name>
                    <name>
                      <surname>Kasturi</surname>
                      <given-names>S.P.</given-names>
                    </name>
                    <name>
                      <surname>Khan</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>G.-M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Systems biology of vaccination for seasonal influenza in humans</article-title>
                  <source>Nat. Immunol.</source>
                  <year>2011</year>
                  <volume>12</volume>
                  <fpage>786</fpage>
                  <lpage>795</lpage>
                  <pub-id pub-id-type="doi">10.1038/ni.2067</pub-id>
                  <pub-id pub-id-type="pmid">21743478</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-viruses-14-02763">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Nakaya</surname>
                      <given-names>H.I.</given-names>
                    </name>
                    <name>
                      <surname>Kazmin</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Oh</surname>
                      <given-names>J.Z.</given-names>
                    </name>
                    <name>
                      <surname>Pulendran</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Systems biological approaches to measure and understand vaccine immunity in humans</article-title>
                  <source>Semin. Immunol.</source>
                  <year>2013</year>
                  <volume>25</volume>
                  <fpage>209</fpage>
                  <lpage>218</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.smim.2013.05.003</pub-id>
                  <pub-id pub-id-type="pmid">23796714</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-viruses-14-02763">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pulendran</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Systems vaccinology: Probing humanity’s diverse immune systems with vaccines</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <year>2014</year>
                  <volume>111</volume>
                  <fpage>12300</fpage>
                  <lpage>12306</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1400476111</pub-id>
                  <pub-id pub-id-type="pmid">25136102</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-viruses-14-02763">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chawla</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Hardingham</surname>
                      <given-names>G.E.</given-names>
                    </name>
                    <name>
                      <surname>Quinn</surname>
                      <given-names>D.R.</given-names>
                    </name>
                    <name>
                      <surname>Bading</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>CBP: A signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV</article-title>
                  <source>Science</source>
                  <year>1998</year>
                  <volume>281</volume>
                  <fpage>1505</fpage>
                  <lpage>1509</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.281.5382.1505</pub-id>
                  <pub-id pub-id-type="pmid">9727976</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-viruses-14-02763">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Filip</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Klug</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Cayli</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Fröhlich</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Henke</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Lacher</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Eickhoff</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Bulau</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Linder</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Carlsson-Skwirut</surname>
                      <given-names>C.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2009</year>
                  <volume>284</volume>
                  <fpage>7977</fpage>
                  <lpage>7985</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M808620200</pub-id>
                  <pub-id pub-id-type="pmid">19155217</pub-id>
                </element-citation>
              </ref>
              <ref id="B35-viruses-14-02763">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roger</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Ding</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Chanson</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Renner</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Calandra</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression</article-title>
                  <source>Eur. J. Immunol.</source>
                  <year>2007</year>
                  <volume>37</volume>
                  <fpage>3509</fpage>
                  <lpage>3521</lpage>
                  <pub-id pub-id-type="doi">10.1002/eji.200737357</pub-id>
                  <?supplied-pmid 18034423?>
                  <pub-id pub-id-type="pmid">18034423</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-viruses-14-02763">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nagai-Singer</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Morrison</surname>
                      <given-names>H.A.</given-names>
                    </name>
                    <name>
                      <surname>Allen</surname>
                      <given-names>I.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>NLRX1 Is a Multifaceted and Enigmatic Regulator of Immune System Function</article-title>
                  <source>Front. Immunol.</source>
                  <year>2019</year>
                  <volume>10</volume>
                  <fpage>2419</fpage>
                  <pub-id pub-id-type="doi">10.3389/fimmu.2019.02419</pub-id>
                  <?supplied-pmid 31681307?>
                  <pub-id pub-id-type="pmid">31681307</pub-id>
                </element-citation>
              </ref>
              <ref id="B37-viruses-14-02763">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kanehisa</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Goto</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>KEGG: Kyoto encyclopedia of genes and genomes</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2000</year>
                  <volume>28</volume>
                  <fpage>27</fpage>
                  <lpage>30</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id>
                  <?supplied-pmid 10592173?>
                  <pub-id pub-id-type="pmid">10592173</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-viruses-14-02763">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Katagiri</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hattori</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Minato</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Kinashi</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Rap1 functions as a key regulator of T-cell and antigen-presenting cell interactions and modulates T-cell responses</article-title>
                  <source>Mol. Cell. Biol.</source>
                  <year>2002</year>
                  <volume>22</volume>
                  <fpage>1001</fpage>
                  <lpage>1015</lpage>
                  <pub-id pub-id-type="doi">10.1128/MCB.22.4.1001-1015.2002</pub-id>
                  <?supplied-pmid 11809793?>
                  <pub-id pub-id-type="pmid">11809793</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-viruses-14-02763">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Voigt</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Grill</surname>
                      <given-names>D.E.</given-names>
                    </name>
                    <name>
                      <surname>Zimmermann</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Simon</surname>
                      <given-names>W.L.</given-names>
                    </name>
                    <name>
                      <surname>Ovsyannikova</surname>
                      <given-names>I.G.</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Poland</surname>
                      <given-names>G.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering</article-title>
                  <source>Sci. Rep.</source>
                  <year>2018</year>
                  <volume>8</volume>
                  <fpage>739</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-017-17735-x</pub-id>
                  <pub-id pub-id-type="pmid">29335477</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-viruses-14-02763">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nakaya</surname>
                      <given-names>H.I.</given-names>
                    </name>
                    <name>
                      <surname>Clutterbuck</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Kazmin</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Cortese</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bosinger</surname>
                      <given-names>S.E.</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>N.B.</given-names>
                    </name>
                    <name>
                      <surname>Zak</surname>
                      <given-names>D.E.</given-names>
                    </name>
                    <name>
                      <surname>Aderem</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Dong</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <year>2016</year>
                  <volume>113</volume>
                  <fpage>1853</fpage>
                  <lpage>1858</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1519690113</pub-id>
                  <pub-id pub-id-type="pmid">26755593</pub-id>
                </element-citation>
              </ref>
              <ref id="B41-viruses-14-02763">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wen</surname>
                      <given-names>A.Y.</given-names>
                    </name>
                    <name>
                      <surname>Sakamoto</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>L.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>The role of the transcription factor CREB in immune function</article-title>
                  <source>J. Immunol.</source>
                  <year>2010</year>
                  <volume>185</volume>
                  <fpage>6413</fpage>
                  <lpage>6419</lpage>
                  <pub-id pub-id-type="doi">10.4049/jimmunol.1001829</pub-id>
                  <pub-id pub-id-type="pmid">21084670</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-viruses-14-02763">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barton</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Muthusamy</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Chanyangam</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Fischer</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Clendenin</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Leiden</surname>
                      <given-names>J.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB</article-title>
                  <source>Nature</source>
                  <year>1996</year>
                  <volume>379</volume>
                  <fpage>81</fpage>
                  <lpage>85</lpage>
                  <pub-id pub-id-type="doi">10.1038/379081a0</pub-id>
                  <pub-id pub-id-type="pmid">8538746</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-viruses-14-02763">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Rincon</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Flavell</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Aune</surname>
                      <given-names>T.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Defective Th function induced by a dominant-negative cAMP response element binding protein mutation is reversed by Bcl-2</article-title>
                  <source>J. Immunol.</source>
                  <year>2000</year>
                  <volume>165</volume>
                  <fpage>1762</fpage>
                  <lpage>1770</lpage>
                  <pub-id pub-id-type="doi">10.4049/jimmunol.165.4.1762</pub-id>
                  <pub-id pub-id-type="pmid">10925253</pub-id>
                </element-citation>
              </ref>
              <ref id="B44-viruses-14-02763">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Scherlinger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Pan</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Tsokos</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Tsokos</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>CaMK4 Controls the Humoral Response via the T Follicular Helper Compartment and Regulates Autoimmunity</article-title>
                  <source>Arthritis Rheumatol.</source>
                  <year>2022</year>
                  <volume>74</volume>
                  <issue>(Suppl. 9)</issue>
                  <fpage>8524</fpage>
                  <comment>Available online: <ext-link xlink:href="https://acrabstracts.org/abstract/camk4-controls-the-humoral-response-via-the-t-follicular-helper-compartment-and-regulates-autoimmunity/" ext-link-type="uri">https://acrabstracts.org/abstract/camk4-controls-the-humoral-response-via-the-t-follicular-helper-compartment-and-regulates-autoimmunity/</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2022-12-05">(accessed on 5 December 2022)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B45-viruses-14-02763">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaiser</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Wiggin</surname>
                      <given-names>G.R.</given-names>
                    </name>
                    <name>
                      <surname>Lightfoot</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Arthur</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Macdonald</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>MSK regulate TCR-induced CREB phosphorylation but not immediate early gene transcription</article-title>
                  <source>Eur. J. Immunol.</source>
                  <year>2007</year>
                  <volume>37</volume>
                  <fpage>2583</fpage>
                  <lpage>2595</lpage>
                  <pub-id pub-id-type="doi">10.1002/eji.200636606</pub-id>
                  <?supplied-pmid 17668895?>
                  <pub-id pub-id-type="pmid">17668895</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-viruses-14-02763">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yu</surname>
                      <given-names>C.T.</given-names>
                    </name>
                    <name>
                      <surname>Shih</surname>
                      <given-names>H.M.</given-names>
                    </name>
                    <name>
                      <surname>Lai</surname>
                      <given-names>M.Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Multiple signals required for cyclic AMP-responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation</article-title>
                  <source>J. Immunol.</source>
                  <year>2001</year>
                  <volume>166</volume>
                  <fpage>284</fpage>
                  <lpage>292</lpage>
                  <pub-id pub-id-type="doi">10.4049/jimmunol.166.1.284</pub-id>
                  <?supplied-pmid 11123304?>
                  <pub-id pub-id-type="pmid">11123304</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-viruses-14-02763">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hu</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Chrivia</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ghosh</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Regulation of CBP-mediated transcription by neuronal calcium signaling</article-title>
                  <source>Neuron</source>
                  <year>1999</year>
                  <volume>22</volume>
                  <fpage>799</fpage>
                  <lpage>808</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80738-2</pub-id>
                  <?supplied-pmid 10230799?>
                  <pub-id pub-id-type="pmid">10230799</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-viruses-14-02763">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Anderson</surname>
                      <given-names>K.A.</given-names>
                    </name>
                    <name>
                      <surname>Means</surname>
                      <given-names>A.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Defective signaling in a subpopulation of CD4<sup>+</sup> T cells in the absence of Ca<sup>2+</sup>/calmodulin-dependent protein kinase IV</article-title>
                  <source>Mol. Cell. Biol.</source>
                  <year>2002</year>
                  <volume>22</volume>
                  <fpage>23</fpage>
                  <lpage>29</lpage>
                  <pub-id pub-id-type="doi">10.1128/MCB.22.1.23-29.2002</pub-id>
                  <?supplied-pmid 11739719?>
                  <pub-id pub-id-type="pmid">11739719</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-viruses-14-02763">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Illario</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Giardino-Torchia</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Sankar</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Ribar</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Galgani</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Vitiello</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Masci</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Bertani</surname>
                      <given-names>F.R.</given-names>
                    </name>
                    <name>
                      <surname>Ciaglia</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Astone</surname>
                      <given-names>D.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells</article-title>
                  <source>Blood</source>
                  <year>2008</year>
                  <volume>111</volume>
                  <fpage>723</fpage>
                  <lpage>731</lpage>
                  <pub-id pub-id-type="doi">10.1182/blood-2007-05-091173</pub-id>
                  <pub-id pub-id-type="pmid">17909078</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-viruses-14-02763">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kanwisher</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>McDermott</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Chun</surname>
                      <given-names>M.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>The fusiform face area: A module in human extrastriate cortex specialized for face perception</article-title>
                  <source>J. Neurosci.</source>
                  <year>1997</year>
                  <volume>17</volume>
                  <fpage>4302</fpage>
                  <lpage>4311</lpage>
                  <pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-11-04302.1997</pub-id>
                  <pub-id pub-id-type="pmid">9151747</pub-id>
                </element-citation>
              </ref>
              <ref id="B51-viruses-14-02763">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Trebak</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kinet</surname>
                      <given-names>J.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Calcium signalling in T cells</article-title>
                  <source>Nat. Rev. Immunol.</source>
                  <year>2019</year>
                  <volume>19</volume>
                  <fpage>154</fpage>
                  <lpage>169</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41577-018-0110-7</pub-id>
                  <pub-id pub-id-type="pmid">30622345</pub-id>
                </element-citation>
              </ref>
              <ref id="B52-viruses-14-02763">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vono</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Taccone</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Caccin</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Gallotta</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Donvito</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Falzoni</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Palmieri</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Pallaoro</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rappuoli</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Di Virgilio</surname>
                      <given-names>F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <year>2013</year>
                  <volume>110</volume>
                  <fpage>21095</fpage>
                  <lpage>21100</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1319784110</pub-id>
                  <?supplied-pmid 24324152?>
                  <pub-id pub-id-type="pmid">24324152</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="viruses-14-02763-f001">
              <label>Figure 1</label>
              <caption>
                <p><bold>Study design.</bold> Of the 234 subjects enrolled (aged ≥65), an equal number (n = 117) of subjects was randomly allocated to receive either high-dose Fluzone or MF59-adjuvanted Fluad influenza vaccine. Blood was sampled before immunization (Day 0/baseline) and 28 days after immunization (Day 28). Humoral immune responses against the influenza A/H3N2 virus were assessed in serum using the hemagglutination inhibition assay (HAI). Gene expression was profiled in purified CD4<sup>+</sup> T cells isolated from PBMCs. The effect of the interaction of CD4<sup>+</sup> T cell gene expression by vaccine type on antibody titer was evaluated using linear regression models (see Methods).</p>
              </caption>
              <graphic xlink:href="viruses-14-02763-g001" position="float"/>
            </fig>
            <fig position="float" id="viruses-14-02763-f002">
              <label>Figure 2</label>
              <caption>
                <p><bold>Differential effect of selected significant genes on immune outcome in the two vaccine groups.</bold> Interaction plots for <italic toggle="yes">CAMK4</italic> (<bold>A</bold>), <italic toggle="yes">TMEM38B</italic> (<bold>B</bold>), <italic toggle="yes">CREBBP</italic> (<bold>C</bold>), and <italic toggle="yes">GATA3</italic> gene (<bold>D</bold>) demonstrate the differential effect on the immune outcome by vaccine type (i.e., the different trajectories of association for the Fluad (solid line, circles) versus Fluzone (dashed line, triangles) vaccines for the specific genes. The horizontal axis represents the standardized gene expression Day 28/Day 0 change (gene expression minus the mean divided by the standard deviation); a one unit change in the standard gene expression is equivalent to a one standard deviation change in gene expression. The vertical axis is the log<sub>2</sub> change in HAI titer from Day 0 to Day 28; a one unit increase in the log2 HAI measure represents a doubling of the HAI titer from Day 0 to Day 28.</p>
              </caption>
              <graphic xlink:href="viruses-14-02763-g002" position="float"/>
            </fig>
            <table-wrap position="float" id="viruses-14-02763-t001">
              <object-id pub-id-type="pii">viruses-14-02763-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>Demographic and clinical variables of the study cohort.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variables</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Fluad (n = 117)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Fluzone (n = 117)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total (n = 234)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value </th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Sex</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.418 *</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> Female</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">76 (65.0%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">70 (59.8%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">146 (62.4%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Male</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41 (35.0%)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47 (40.2%)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88 (37.6%)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td colspan="2" align="left" valign="middle" rowspan="1">Age at enrollment (years)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.556 **</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> Median</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">71.900</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">71.100</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">71.500</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Q1, Q3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.200, 76.500</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.700, 75.600</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.900, 76.000</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Ethnicity</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.000 *</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> Non-Hispanic or Latino</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">115 (98.3%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">115 (98.3%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">230 (98.3%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Hispanic or Latino</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (1.7%)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (1.7%)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (1.7%)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Race</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.316 *</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> Black or African American</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1 (0.9%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0 (0.0%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1 (0.4%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> White</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">116 (99.1%)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">117 (100.0%)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">233 (99.6%)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td colspan="2" align="left" valign="middle" rowspan="1">Weight (kg)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.977 **</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> Median</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">79.5</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">81.1</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">80.3</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Q1, Q3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.9, 91.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.1, 90.7</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.5, 91.0</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td colspan="2" align="left" valign="middle" rowspan="1">Height (cm)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.221 **</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> Median</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">164.4</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">165.9</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">164.9</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Q1, Q3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">159.1, 173.5</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">161.2, 175.2</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">160.1, 174.4</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BMI</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.333 **</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> Median</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">28.7</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">28.0</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">28.3</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Q1, Q3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.3, 31.9</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.9, 31.1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.2, 31.6</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td colspan="2" align="left" valign="middle" rowspan="1">HAI titer (Day 28/Day 0) ***</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.062 **</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1"> Median</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.000</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.000</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.000</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Q1, Q3</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000, 2.000</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.000, 2.000</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.000, 2.000</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>* Pearson’s Chi-squared test. ** Wilcoxon rank sum test. *** Influenza A/H3N2 HAI antibody titer (log<sub>2</sub> change in HAI titer from Day 0 to Day 28).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="viruses-14-02763-t002">
              <object-id pub-id-type="pii">viruses-14-02763-t002_Table 2</object-id>
              <label>Table 2</label>
              <caption>
                <p>Influence of vaccine type and CD4<sup>+</sup> T cell gene expression change on Ab response to influenza vaccination (Day 28-Day 0 HAI titer change). Full list of genes is expanded in <xref rid="app1-viruses-14-02763" ref-type="app">Supplementary Table S1</xref>.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th colspan="5" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#BFBFBF" rowspan="1">Day 28/Day 0 Gene Expression Change (Interaction Model 1) *</th>
                  </tr>
                  <tr>
                    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gene Symbol</th>
                    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Entrezgene Description</th>
                    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Estimate</th>
                    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value **</th>
                    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">q-Value ***</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">SLC2A11</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">solute carrier family 2 member 11</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.6034</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">8.19 × 10<sup>−6</sup></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0701</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">RP11-779O18.2</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">pre-mRNA processing factor 31</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.5604</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2.65 × 10<sup>−5</sup></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1137</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">SLC38A5</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">solute carrier family 38 member 5</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.5324</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0001</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">WDR35</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">WD repeat domain 35 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.5332</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0001</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">APOBR</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">apolipoprotein B receptor</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.5347</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0001</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">CC2D1A</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">coiled-coil and C2 domain containing 1A</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4902</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0002</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MYO9B</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">myosin IXB </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.5059</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0002</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">PRKD2</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">protein kinase D2 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.5016</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0002</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">SLC25A53</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">solute carrier family 25 member 53</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4843</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0003</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">TMEM38B</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">transmembrane protein 38B </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4931</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0003</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">B4GALT4</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">beta-1,4-galactosyltransferase 4 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4931</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0003</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">SLC23A3</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">solute carrier family 23 member 3</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4830</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0003</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">GORASP1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">golgi reassembly stacking protein 1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4830</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0004</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">ERLIN2</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ER lipid raft associated 2</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4828</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0004</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">PITPNM1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">phosphatidylinositol transfer protein membrane-associated 1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4753</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0004</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MAP4</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">microtubule associated protein 4</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4993</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0004</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MVB12B</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">multivesicular body subunit 12B</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4904</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0004</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">PKIG</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">cAMP-dependent protein kinase inhibitor gamma</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4634</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0005</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">POP5</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">POP5 homolog, ribonuclease P/MRP subunit</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4947</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0005</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic toggle="yes">C17orf51</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">long intergenic non-protein coding RNA 2693</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4690</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0005</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">PLEKHG5</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">pleckstrin homology and RhoGEF domain containing G5</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4809</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0005</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">CAMK4</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">calcium-/calmodulin-dependent protein kinase IV </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4991</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0008</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1575</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">PIAS3</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">protein inhibitor of activated STAT 3</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4458</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0009</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1598</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">TRAF7</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">TNF receptor-associated factor 7</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4395</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0012</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1684</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">COX6B1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">cytochrome c oxidase subunit 6B1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4254</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0017</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1783</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">GATA3</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">GATA-binding protein 3</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4358</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0019</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1861</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">IL36A</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">interleukin 36 alpha</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4159</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0024</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1967</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MAP3K13</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">mitogen-activated protein kinase 13</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4208</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0025</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.1995</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic toggle="yes">CREBBP</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CREB-binding protein</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.3594</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0086</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2562</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>* Top 20 genes from the model are presented, followed by other significant genes/finding (below the line), with a link to T cell differentiation/activation/function, resulting from this model. ** <italic toggle="yes">p</italic>-values are from the interaction term of the linear model. *** Q-values were calculated using Storey’s method (see Methods).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="viruses-14-02763-t003">
              <object-id pub-id-type="pii">viruses-14-02763-t003_Table 3</object-id>
              <label>Table 3</label>
              <caption>
                <p>Influence of CD4+ T cell gene expression (Day 0 or Day 28) on Ab response to influenza vaccination by vaccine type.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <tbody>
                  <tr>
                    <td colspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#BFBFBF" rowspan="1">
                      <bold>Baseline (Day 0) Gene Expression (Interaction Model 2) *</bold>
                    </td>
                    <td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#BFBFBF" rowspan="1" colspan="1">
</td>
                    <td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#BFBFBF" rowspan="1" colspan="1">
</td>
                    <td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin;background:#BFBFBF" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold>Gene Symbol</bold>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold>Entrezgene Description</bold>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold>Estimate</bold>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold><italic toggle="yes">p</italic>-Value **</bold>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold>q-Value ***</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">FAM136A</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">family with sequence similarity 136 member A </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.5098</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0002</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">POLA1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">DNA polymerase alpha 1, catalytic subunit </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4990</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0002</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">CCER2</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">coiled-coil glutamate rich protein 2</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4806</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0004</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MLLT4/AFDN</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">afadin, adherens junction formation factor </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4812</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0004</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">AMY2B</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">amylase alpha 2B</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4763</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0004</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">HECTD3</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">HECT domain E3 ubiquitin protein ligase 3 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4935</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0005</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">C2orf66</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">chromosome 2 open reading frame 66</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4616</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0006</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">PIGW</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">phosphatidylinositol glycan anchor biosynthesis class W </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4605</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0006</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">SLC23A3</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">solute carrier family 23 member 3</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4616</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0006</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">BAIAP3</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BAI1-associated protein 3 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4622</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0007</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">ITIH4</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">inter-alpha-trypsin inhibitor heavy chain 4</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4559</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0007</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MUSTN1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">musculoskeletal, embryonic nuclear protein 1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4587</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0007</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MBTPS2</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">membrane bound transcription factor peptidase, site 2 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4660</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0008</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MYO19</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">myosin XIX</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4509</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0008</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">NLRX1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">NLR family member X1 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4588</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0009</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">RP5-966M1.6</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SREBF2 antisense RNA 1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4501</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0009</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">PIAS3</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">protein inhibitor of activated STAT 3</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4545</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0009</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">C14orf119</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">chromosome 14 open reading frame 119 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.4441</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0010</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">ALDH8A1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">aldehyde dehydrogenase 8 family member A1 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4435</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0011</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic toggle="yes">MRPS28</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mitochondrial ribosomal protein S28</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−0.4512</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0012</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4912</td>
                  </tr>
                  <tr>
                    <td colspan="2" align="left" valign="middle" style="border-bottom:solid thin;background:#BFBFBF" rowspan="1">
                      <bold>Day 28 Gene Expression (Interaction Model 3) *</bold>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin;background:#BFBFBF" rowspan="1" colspan="1">
</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin;background:#BFBFBF" rowspan="1" colspan="1">
</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin;background:#BFBFBF" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold>Gene Symbol</bold>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold>Entrezgene Description</bold>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold>Estimate</bold>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold><italic toggle="yes">p</italic>-Value **</bold>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold>q-Value ***</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">COQ4</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">coenzyme Q4</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.5698</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2.15 × 10<sup>−5</sup></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.2293</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">EEFSEC</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">eukaryotic elongation factor, selenocysteine tRNA-specific</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">−0.5304</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0001</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.3727</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">NEIL1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">nei-like DNA glycosylase 1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.5243</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0001</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.3727</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">SLC25A14</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">solute carrier family 25 member 14</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.5000</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0002</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4405</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">CNTD2/CCNP</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">cyclin P</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4896</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0003</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4405</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">PSMC3IP</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PSMC3 interacting protein</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4946</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0003</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4405</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">PPM1N</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">protein phosphatase, Mg2+/Mn2+-dependent 1N</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4857</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0003</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4405</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MYO19</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">myosin XIX</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4800</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0003</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4405</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">BAIAP3</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BAI1-associated protein 3</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4668</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0007</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7302</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">BIVM</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">basic, immunoglobulin-like variable motif containing</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4614</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0008</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7302</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">ECHDC2</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">enoyl-CoA hydratase domain containing 2</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4586</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0008</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7302</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">TTC8</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">tetratricopeptide repeat domain 8 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4493</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0008</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7364</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">POGLUT1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">protein O-glucosyltransferase 1 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4451</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0009</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7598</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">TRIP6</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">thyroid hormone receptor interactor 6</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4316</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0011</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7658</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">SAPCD1</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">suppressor APC domain containing 1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4472</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0012</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7658</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">CYP4F12</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">cytochrome P450 family 4 subfamily F member 12 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4541</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0014</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7658</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">MFI2/MELTF</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">melanotransferrin </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4405</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0014</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7658</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">LPPR2/PLPPR2</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">phospholipid phosphatase-related 2 </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4282</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0014</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7658</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">
                      <italic toggle="yes">FN3KRP</italic>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">fructosamine 3 kinase-related protein </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.4198</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.0016</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.7658</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic toggle="yes">RABL2A</italic>
                    </td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RAB, member of RAS oncogene family-like 2A</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4191</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0016</td>
                    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7658</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>* Top 20 genes from the model are presented. ** <italic toggle="yes">p</italic>-values are from the interaction term of the linear model. *** Q-values were calculated using the Storey’s method (see Methods). In summary, our most significant and biologically meaningful transcriptomic signatures resulted from interaction model 1, which uses CD4<sup>+</sup> gene expression change (Day 28/Day 0 gene expression change), rather than Day 0 gene expression or Day 28 gene expression.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="viruses-14-02763-t004">
              <object-id pub-id-type="pii">viruses-14-02763-t004_Table 4</object-id>
              <label>Table 4</label>
              <caption>
                <p>Enriched biological pathways/processes involved in the CD4+ T cell activation by vaccine type (from interaction model 1: Day 28/Day 0 gene expression effect on immune outcome by vaccine type).</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">KEGG Pathway *</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Set Size</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FDR ***</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Herpes simplex virus 1 infection</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">388</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.48 × 10<sup>−6</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.001</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MAPK signaling pathway **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">150</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3.11 × 10<sup>−6</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.001</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Endocytosis</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">142</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2.60 × 10<sup>−5</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.003</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Human papillomavirus infection</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">158</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3.77 × 10<sup>−5</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.003</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Thyroid hormone signaling pathway</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">69</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.57 × 10<sup>−5</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.003</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Kaposi sarcoma-associated herpesvirus infection</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">101</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3.19 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.011</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Tight junction **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">81</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3.38 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.011</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">C-type lectin receptor signaling pathway</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">56</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3.54 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.011</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Folate biosynthesis</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">14</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.15 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.011</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">PD-L1 expression and PD-1 checkpoint pathway in cancer</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">45</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.18 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.011</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Glucagon signaling pathway</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">51</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.18 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.011</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Rap1 signaling pathway **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">100</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.56 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.011</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Relaxin signaling pathway</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">55</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.59 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.011</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">TNF signaling pathway **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">62</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6.22 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.013</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">GnRH signaling pathway</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">44</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6.59 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.013</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">NOD-like receptor signaling pathway **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">95</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">9.54 × 10<sup>−4</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.017</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Hepatitis B</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">84</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.08 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.018</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Glycosaminoglycan biosynthesis—chondroitin/dermatan sulfate</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">16</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.24 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.019</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Notch signaling pathway **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">40</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.34 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.020</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Human T-cell leukemia virus 1 infection</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">128</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.45 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.020</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Glutamatergic synapse</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">44</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.67 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.022</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">IL-17 signaling pathway **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">40</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1.78 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.023</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Transcriptional misregulation in cancer</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">103</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2.01 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.025</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Human cytomegalovirus infection</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">112</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2.52 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.028</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Epstein-Barr virus infection</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">114</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2.66 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.028</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Phospholipase D signaling pathway</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">69</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2.72 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.028</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Viral carcinogenesis</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">110</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2.96 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.029</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Calcium signaling pathway **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">90</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2.96 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.029</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Neutrophil extracellular trap formation</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">87</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3.05 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.029</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Estrogen signaling pathway</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">56</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3.14 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.029</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">AGE-RAGE signaling pathway in diabetic complications</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">52</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3.50 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.030</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Growth hormone synthesis, secretion, and action</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">55</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.56 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.036</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Circadian entrainment</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">39</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.63 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.036</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Serotonergic synapse</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">41</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.94 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.038</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Insulin signaling pathway</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">72</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5.22 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.039</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">RNA polymerase</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">29</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6.12 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.044</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Inflammatory mediator regulation of TRP channels **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">49</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6.28 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.044</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Fatty acid elongation</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">16</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6.55 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.045</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Th1 and Th2 cell differentiation **</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">50</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.04 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.046</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Necroptosis</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">76</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.04 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.046</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Dopaminergic synapse</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">55</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.21 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.047</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apoptosis **</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.35 × 10<sup>−3</sup></td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.047</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>* From the enriched pathways list, we removed pathways associated with diseases that arose from combinations of other pathways. ** Pathways related to T cell differentiation, activation, and function are bolded. *** FDRs were calculated using Benjamini–Hochberg method (Methods).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
